openPR Logo
Press release

Ioversol Market Competitive Status and Trend Estimate with Top Players Guerbet, Jiangsu Hengrui Medicine Co., Mallinckrodt Pharmaceuticals, Ultraject

04-17-2019 12:38 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Coherent Market Insights

Ioversol Market

Ioversol Market

Ioversol is a white to off-white crystalline powder having a crystalline sulfide-like odor. It is a non-ionic radiological contrast agent that is included in a group of drugs known as radiopaque contrast agents. It contains iodine, a substance that has the ability to absorb x-rays. Ioversol allows the blood vessels, organs and others non-bony tissues of the body to be seen more clearly during a CT scan or similar radiologic (x-ray) examination. Ioversol is injected into an artery or vein through an IV (Intravenous). The uniqueness and versatility of ioversol has also expanded its use in magnetic resonance imaging and ultrasound scattering. Ioversol is also used for the treatment, control, prevention and improvement of heart disorders, brain disorders and blood vessel disorders. Ioversol is generally not given on dosage. However, in some cases, a dosage of ioversol is given to the patient based on the condition he/she is being treated, how patient respond to this drug, patient’s weight, height, age, and gender, etc. CMI predicts the global Ioversal market to grow at a healthy growth rate over the forecast period owing to an escalating demand for ioversol among consumers and clinics.

The market for ioversol is mainly driven by the robustly growing imaging and x-ray market. Rising prevalence of cardiovascular disorders is giving pace to x-ray industry and thus the ioversol market. Bone-related challenges and diseases, rising accidents and kidney related problems are the key drivers for growth of the ioversol industry. Another factor boosting growth of the global ioversol market is the growing geriatric population which are more prone to orthopedic disorders than the younger demographics. However, factors such as allergic reaction by use of ioversol, swelling, difficulty in breathing, rapid weight gain, joint pain or stiffness, muscle pain or weakness, nausea, sweating, etc. may hamper the demand for ioversol in the near future. Advancements in the computed tomography (CT) technology can prove to be a lucrative factor for market growth over the forecast period.

Request For Sample Copy:
https://www.coherentmarketinsights.com/insight/request-sample/386

Ioversol 64% Injectable Solution, made from 636 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of calcium disodium as a stabilizer, is the most commonly used ioversol type primarily owing to high scope of application, ease of use and low cost. On the basis of application, the x-ray segment is forecast to grow at the fastest rate over the forecast period owing to the growing demand for ioversol in angiography, tomography, urography and others.

Market Outlook - Asia Pacific is expected to be the most lucrative region for the key players operating in the global Ioversol market

On the basis of geography, the global ioversol market is segmented into North America, Latin America, Europe, Middle East, Asia-Pacific and Africa. Market of Ioversol is anticipated to witness a high demand in the Asia-Pacific region owing to the constant rise in pharmaceutical spending, increasing awareness regarding the use of ioversol and the growing population base, particularly in countries such as China and India. North America is currently the second largest market for ioversol and is expected to grow at an above average growth rate over the forecast period. Europe is expected to showcase a sluggish growth during the forecast period owing to the maturing pharmaceutical industry.

The key players profiled in the global ioversol market are Liebel-Flarsheim Company LLC, Guerbet, Jiangsu Hengrui Medicine Co., Mallinckrodt Pharmaceuticals, Ultraject, China Resources Pharmaceutical Co., HB Ocean, Changzhou Highassay Chemical Co., Ltd., and various others. Major players in the market are focused on product launches and organic growth by means of mergers and acquisitions.

Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/386

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ioversol Market Competitive Status and Trend Estimate with Top Players Guerbet, Jiangsu Hengrui Medicine Co., Mallinckrodt Pharmaceuticals, Ultraject here

News-ID: 1706958 • Views:

More Releases from Coherent Market Insights

Global And China Osteoporosis Drugs Market Growth in Future Scope 2025-2032 | Merck KGaA, Lilly, Procter & Gamble, Enzo Biochem Inc.
Global And China Osteoporosis Drugs Market Growth in Future Scope 2025-2032 | Me …
Global And China Osteoporosis Drugs Market is estimated to be valued at USD 15.76 Bn in 2025 and is expected to reach USD 20.6 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 3.9% from 2025 to 2032. The Global Business Landscape is being reshaped by rapid innovation, rising investment and shifting regional dynamics - and at the heart of this transformation lies the Global And China Osteoporosis Drugs
Dental Rapid Prototyping Systems Market Size 2025: Global Share, Industry And Report Analysis By 2032 |3M, A-dec Inc, AMD Lasers, BIOLASE
Dental Rapid Prototyping Systems Market Size 2025: Global Share, Industry And Re …
Dental Rapid Prototyping Systems Market is estimated to be valued at USD 4.87 Bn in 2025 and is expected to reach USD 19.37 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 21.8% from 2025 to 2032. The Global Business Landscape is being reshaped by rapid innovation, rising investment and shifting regional dynamics - and at the heart of this transformation lies the Dental Rapid Prototyping Systems Market. From
U.S. Vaccine Market Set to Significantly Grow from 2025 to 2032 |Sanofi Pasteur, GlaxoSmithKline Plc, Merck & Company Incorporated, Pfizer Incorporated
U.S. Vaccine Market Set to Significantly Grow from 2025 to 2032 |Sanofi Pasteur, …
U.S. Vaccine Market is estimated to be valued at USD 26.59 Bn in 2025 and is expected to reach USD 39.2 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 5.7% from 2025 to 2032. The Global Business Landscape is being reshaped by rapid innovation, rising investment and shifting regional dynamics - and at the heart of this transformation lies the U.S. Vaccine Market. From 2025 to 2032,
Global And China Catheter Market In-depth Insights, Business Opportunities and Top Companies Analysis Forecast by 2032 |Cordis (Cardinal Health), Abbott Laboratories, B. BRAUN, Medtronic plc
Global And China Catheter Market In-depth Insights, Business Opportunities and T …
Global And China Catheter Market is estimated to be valued at USD 51.7 Bn in 2025 and is expected to reach USD 73.23 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 5.1% from 2025 to 2032. The Global Business Landscape is being reshaped by rapid innovation, rising investment and shifting regional dynamics - and at the heart of this transformation lies the Global And China Catheter Market. From

All 5 Releases


More Releases for Ioversol

Global Ioversol Market Imapct of AI and Automation
Ioversol Market Impact of AI and Automation The Ioversol market, a crucial segment in the radiology and imaging industry, was valued at approximately $350 million in 2022. With a compound annual growth rate (CAGR) of 5.4%, the market is projected to reach around $450 million by 2027. This growth trajectory is driven by an increasing demand for advanced imaging techniques and rising prevalence of diagnostic procedures. The expansion is reflective of
Global Ioversol Market Imapct of AI and Automation
Ioversol Market Impact of AI and Automation The Ioversol market, a crucial segment in the radiology and imaging industry, was valued at approximately $350 million in 2022. With a compound annual growth rate (CAGR) of 5.4%, the market is projected to reach around $450 million by 2027. This growth trajectory is driven by an increasing demand for advanced imaging techniques and rising prevalence of diagnostic procedures. The expansion is reflective of
Ioversol Injection Market Outlook and Future Projections for 2030
The ioversol injection market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines the current
Ioversol Market Trends, Outlook, and Opportunity Analysis, 2018-2026
Ioversol is a white to off-white crystalline powder having a crystalline sulfide-like odor. It is a non-ionic radiological contrast agent that is included in a group of drugs known as radiopaque contrast agents. It contains iodine, a substance that has the ability to absorb x-rays. Ioversol allows the blood vessels, organs and others non-bony tissues of the body to be seen more clearly during a CT scan or similar radiologic
Ioversol Market Report 2018: Segmentation by Type (Ioversol 34% Injectable Solut …
Global Ioversol market research report provides company profile for China Resources Pharmaceutical (Shanghai) Co, HB Ocean, Novalek Pharmaceuticals Pvt. Ltd, Stellence Pharmscience Pvt. Ltd, A.S. Joshi & Company, Liebel-Flarsheim Company LLC, Guerbet, Jiangsu Hengrui Medicine Co, Mallinckrodt Pharmaceuticals, Ultraject and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of
Ioversol Market Opportunity Analysis, 2018–2026
Ioversol is a white to off-white crystalline powder having a crystalline sulfide-like odor. It is a non-ionic radiological contrast agent that is included in a group of drugs known as radiopaque contrast agents. It contains iodine, a substance that has the ability to absorb x-rays. Ioversol allows the blood vessels, organs and others non-bony tissues of the body to be seen more clearly during a CT scan or similar radiologic